← Leaderboards
Blake Eason Hildreth
Ohio State University
$824,148
Attributed
$824,148
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $126.7K · FY2009–22$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$824,148 · 2
By mechanism
K01$633,690 · 1
F32$190,458 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Michael D Lairmore$5,085,750
- Sarah H Tannehill-Gregg$548,500
- Ramiro Eliseo Toribio$1,088,251
- Patrick Lee Green$10,720,230
- Thomas J Rosol$5,769,258
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPlaySiteBoneProteinsBiologyCessation Of LifeCell Surface ReceptorsClinical ResearchBindingBreast Cancer MetastasisBioluminescenceAntibodiesBisphosphonateBaseCareerCancer BiologyAwardBone NeoplasmsBone ResorptionBrainBreast Cancer CellCancer CellBone Loss
Grant awards (8)
Macrophage and osteoclast specific targeting for the prevention and treatment of breast cancer bone metastasis$126,738
K01 · FY2022 · OD · contact PI
Macrophage and osteoclast specific targeting for the prevention and treatment of breast cancer bone metastasis$126,738
K01 · FY2021 · OD · contact PI
Macrophage and osteoclast specific targeting for the prevention and treatment of breast cancer bone metastasis$126,738
K01 · FY2020 · OD · contact PI
Macrophage and osteoclast specific targeting for the prevention and treatment of breast cancer bone metastasis$126,738
K01 · FY2019 · OD · contact PI
Macrophage and osteoclast specific targeting for the prevention and treatment of breast cancer bone metastasis$126,738
K01 · FY2018 · OD · contact PI
Effects of nuclear PTHrP on bone formation and the skeletal microenvironment$66,462
F32 · FY2011 · AR · contact PI
Effects of nuclear PTHrP on bone formation and the skeletal microenvironment$63,186
F32 · FY2010 · AR · contact PI
Effects of nuclear PTHrP on bone formation and the skeletal microenvironment$60,810
F32 · FY2009 · AR · contact PI